Cell separation technologies Market size is projected to increase at a substantial rate during the forecast period of 2023-2032. One of the major factors favoring the adoption of these technologies is the wide scope of application of isolated cells in various life science research studies, which can enable scientists to conduct molecular and epigenetic analysis.
Biotech research and development activities are also on the rise to create state-of-the-art medical technologies. For example, in September 2022, the U.S. government announced funding of more than USD 2 billion to promote President Joe Biden’s National Biotechnology and Biomanufacturing Initiative. Such investments will propel the development of cell separation technologies, further augmenting the market growth.
There has been a notable increase in the incidence of different types of cancers across the globe. In 2022, the U.S. was expected to record 1.9 million new cancer cases and 609,360 cancer deaths. This scenario has played a vital role in helping cell-based therapy flourish as a research field to assuage symptoms associated with various cancers. Many research institutes are accelerating their efforts to investigate a wide range of cell types for innovative therapeutic uses, such as treating different types of blood cancers. These factors, along with significant improvements in mesenchymal stem cells and other cell-based therapies, will support cell separation technologies market expansion over the coming years.
Based on technology, cell separation technologies market is segmented into fluorescence activated cell sorting (FACS), density gradient centrifugation, immuno-magnetic cell separation, micro fluidic cell separation, and immuno-density cell separation. The industry size from the fluorescence activated cell sorting (FACS) technology segment is anticipated to register a steady CAGR through 2032. This technology has shown greater versatility as compared to other cell separation techniques as it can separate cells based on physical characteristics, such as granularity and surface markers. Since FACS has high throughput, the technology has become a standard in many clinical and research labs, thereby accelerating the market progress.
Based on application, cell separation technologies industry is bifurcated into neuroscience, oncology, stem cell, microbiology, immunobiology, and other research areas. The market value from the stem cell research segment is expected to grow at an appreciable rate as stem cell therapy has gained immense traction in the treatment of a variety of cancers and other chronic diseases.
Using cell separation technologies in stem cell research can help medical researchers get a deeper insight into how chronic health conditions develop. Many governments have realized the potential of stem cell therapy and boosted their investments to enhance research in this area.
Europe cell separation technologies market is predicted to display steady growth during the forecast timeframe as the network of research laboratories is increasing across the region. For example, in 2021, AstraZeneca unveiled a new $1.3 billion research facility in the UK to develop next-generation therapeutics, such as cell therapies. These developments, along with rising cancer cases and investments by UK-based biotech firms to accelerate efforts in the drug discovery process, might amplify the regional industry growth.
GE Healthcare, Thermo Fisher Scientific, EMD Millipore, ZEISS, PerkinElmer, Bio-Rad Laboratories, Akadeum Life Sciences, STEMCELL Technologies, and Miltenyi Biotec, among others, are a few of the top companies involved in cell separation technologies industry.